Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 1;60(1):85.
doi: 10.3390/medicina60010085.

Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome

Affiliations

Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome

Márió Vincze et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Increasing evidence points to the significant role of the angiogenic factor levels in screening for pregnancy outcome. To examine the potential relationship between concentrations of placental protein 13 (PP13) and soluble human leukocyte antigen-G (sHLA-G) in maternal serum and amniotic fluid at 16-23 weeks of gestation and the sonographic features of pregnancy as well as pregnancy outcome. Materials and Methods: PP13 and sHLA-G in serum and amniotic fluid, fetal biometrical data, and placental volume and perfusion indices were determined in 71 euploid, singleton pregnancies. Results: The serum sHLA-G level exhibits a negative correlation with the serum PP13 level (r = -0.186, p < 0.001) and a positive correlation with the sHLA-G level in amniotic fluid (r = 0.662, p < 0.001). A significant correlation was found between serum sHLA-G level and placental volume (r = 0.142, p < 0.05) and between amniotic sHLA-G level and placental perfusion (r = -0.450, p < 0.001). A low amniotic PP13 level significantly predicted the birth weight (r = -0.102, p < 0.05), the duration of pregnancy (r = -0.155, p < 0.05), and the fetal abdominal circumference (r = -0.098, p < 0.05). Conclusions: PP13 assayed in amniotic fluid might be a potential marker of fetal growth, and sHLA-G can be an adjunct modality reflecting placental sonographic parameters.

Keywords: amniotic fluid; placental protein-13; serum; soluble human leukocyte antigen-G; sonography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The secretion of sHLA-G in maternal serum and amniotic fluid.
Figure 2
Figure 2
The secretion of PP13 in maternal serum and amniotic fluid.
Figure 3
Figure 3
The correlation between sHLA-G concentrations in serum and amniotic fluid (p < 0.001).

Similar articles

Cited by

References

    1. Cuffe J.S., Holland O., Salomon C., Rice G.E., Perkins A.V. Review: Placental derived biomarkers of pregnancy disorders. Placenta. 2017;54:104–110. doi: 10.1016/j.placenta.2017.01.119. - DOI - PubMed
    1. Chen D., Zheng J. Regulation of Placental Angiogenesis. Microcirculation. 2014;21:15–25. doi: 10.1111/micc.12093. - DOI - PMC - PubMed
    1. Le Bouteiller P. Human villous trophoblast and the lack of intron 4-retaining soluble HLA-G secretion: Beware of possible methodological biases. Mol. Hum. Reprod. 2005;11:711–713. doi: 10.1093/molehr/gah211. - DOI - PubMed
    1. Morales P.J., Pace J.L., Platt J.S., Langat D.K., Hunt J.S. Synthesis of β2-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology. 2007;122:179–188. doi: 10.1111/j.1365-2567.2007.02623.x. - DOI - PMC - PubMed
    1. Xu X., Zhou Y., Wei H. Roles of HLA-G in the Maternal-Fetal Immune Microenvironment. Front. Immunol. 2020;11:592010. doi: 10.3389/fimmu.2020.592010. - DOI - PMC - PubMed

LinkOut - more resources